Edward Michael Gilbert

Edward Michael Gilbert's AcademicInfluence.com Rankings

Philosophy

#9754

World Rank

#13358

Historical Rank

Logic

#6713

World Rank

#8258

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Edward Michael Gilbert's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Edward Michael Gilbert Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edward Michael Gilbert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. (1996) (3965)
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. (1996) (1327)
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy (1993) (1212)
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. (1996) (667)
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. (1997) (517)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. (2002) (503)
Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. (1996) (472)
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. (1993) (448)
Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. (1995) (394)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. (1990) (356)
The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. (1986) (348)
Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. (1999) (293)
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. (2001) (286)
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. (1989) (284)
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. (1994) (278)
Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. (1990) (271)
A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. (1985) (263)
Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1996) (249)
Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. (1991) (225)
Fluid loading increases oxygen consumption in septic patients with lactic acidosis. (1986) (220)
Safety and efficacy of carvedilol in severe heart failure (1997) (215)
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. (2003) (212)
Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II (2013) (206)
Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. (2013) (178)
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. (1998) (132)
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. (2001) (132)
Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. (1989) (132)
Morbidity and Mortality in Heart Transplant Candidates Supported With Mechanical Circulatory Support: Is Reappraisal of the Current United Network for Organ Sharing Thoracic Organ Allocation Policy Justified? (2012) (131)
Lisinopril Lowers Cardiac Adrenergic Drive and Increases, 8‐Recept or Density in the Failing Human Heart (1993) (118)
Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. (1987) (114)
beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. (1993) (114)
Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. (1999) (113)
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. (1992) (110)
Beta-Adrenergic Receptors, from Their Discovery and Characterization through Their Manipulation to Beneficial Clinical Application (2012) (106)
Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype (2002) (101)
Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. (1995) (93)
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. (1991) (93)
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. (1990) (92)
Prognosis and Management (1993) (91)
Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. (2006) (87)
The role of third‐generation beta‐blocking agents in chronic heart failure (1998) (84)
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. (2009) (81)
Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. (1991) (81)
Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. (2019) (79)
Echocardiographic evaluation of potential cardiac transplant donors. (1988) (78)
Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? (1989) (78)
Effects of carvedilol on right ventricular function in chronic heart failure. (1998) (76)
Percutaneous coronary interventions with stents in cardiac transplant recipients. (2005) (75)
Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. (1986) (74)
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. (2001) (70)
Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies. (2005) (69)
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. (1986) (68)
Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. (2019) (67)
Increased risk of pneumococcal infections in cardiac transplant recipients. (1990) (63)
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. (1996) (62)
A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD‐3 (OKT3) ANTIBODY‐BASED AND EQUINE ANTITHYMOCYTE GLOBULIN‐BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATION (1989) (59)
Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. (1987) (59)
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. (1997) (58)
Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. (1995) (56)
Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. (2016) (56)
A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. (2009) (53)
Structural and Functional Phenotyping of the Failing Heart: Is the Left Ventricular Ejection Fraction Obsolete? (2017) (51)
Exercise capacity after heart transplantation: influence of donor and recipient characteristics. (1996) (51)
Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. (2007) (51)
Age-associated decline in cardiac allograft rejection. (1987) (51)
Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure. (1995) (51)
Use of OKT3 monoclonal antibody in heart transplantation: Review of the initial experience (1988) (49)
Myocardial α- and β-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? (1988) (48)
Early screening for antibody-mediated rejection in heart transplant recipients. (2007) (46)
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. (2007) (45)
Effect of mechanical circulatory support on outcomes after heart transplantation. (2006) (45)
β-Blocker dosing in community-based treatment of heart failure (2007) (44)
A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. (2012) (44)
Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. (2004) (43)
A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction (2017) (43)
The sympathetic nervous system in chronic heart failure. (1998) (41)
Effect of reversible pulmonary hypertension on outcomes after heart transplantation. (2007) (41)
Myocardial microRNAs associated with reverse remodeling in human heart failure. (2017) (40)
Carvedilol improves renal hemodynamics in patients with chronic heart failure (1998) (40)
Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium (2020) (39)
Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. (2005) (38)
Left ventricular mass increases during cardiac allograft vascular rejection. (1995) (38)
Dose-Response of Chronic / 3-Blocker Treatment in Heart Failure From Either Idiopathic Dilated or Ischemic Cardiomyopathy (2005) (38)
Therapeutic Molecular Phenotype of &bgr;-Blocker–Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy (2015) (37)
Effect of carvedilol in severe chronic heart failure (1996) (37)
The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure. (1989) (37)
Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. (2010) (37)
Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias. (1991) (34)
Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study (2010) (34)
Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection. (1987) (34)
Impact of Donor Left Ventricular Hypertrophy on Survival After Heart Transplant (2011) (33)
Reducing the Risk of Sudden Death in Heart Failure With β-Blockers (2006) (32)
Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. (2007) (30)
Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. (2010) (30)
Atrioventricular Junction Ablation Followed by Resynchronization Therapy in Patients with Congestive Heart Failure and Atrial Fibrillation (AVERT‐AF) Study Design (2006) (30)
Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support: The Utah Bleeding Risk Score (2018) (30)
Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function. (2011) (29)
The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. (2010) (28)
Acute hemodynamic effects of carvedilol versus metoprolol in idiopathic dilated cardiomyopathy (1991) (28)
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. (2007) (26)
OKT3 monoclonal antibody in heart transplantation. (1988) (26)
Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. (2016) (26)
Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors. (2005) (24)
Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation? (2010) (21)
Beta-blocker dosing in community-based treatment of heart failure. (2007) (21)
Reducing the risk of sudden death in heart failure with beta-blockers. (2006) (21)
Long-term experience with sotalol in the treatment of complex ventricular arrhythmias. (1987) (21)
TREATMENT OF MYOCARDITIS WITH OKT3 MONOCLONAL ANTIBODY (1988) (21)
Second- and Third-Generation Beta-Blocking Drugs in Chronic Heart Failure (1997) (19)
Comparative hemodynamic effects of milrinone and dobutamine in heart failure patients treated chronically with carvedilol (1998) (19)
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE) * ** (2000) (19)
How do beta-blockers improve ventricular function in patients with congestive heart failure? (2003) (18)
Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? (2011) (18)
Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. (1991) (18)
Myocardial alpha- and beta-adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal? (1988) (18)
Enoximone as a bridge to heart transplantation: the Utah experience. (1991) (18)
Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study. (1987) (18)
Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. (2006) (18)
Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. (2012) (17)
β‐Receptor Selectivity of Carvedilol and Metoprolol Succinate in Patients with Heart Failure (SELECT Trial): A Randomized Dose‐Ranging Trial (2009) (17)
β‐Blockade With Bucindolol in Heart Failure Caused by Ischemic Versus Idiopathic Dilated Cardiomyopathy (1991) (17)
Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. (2010) (16)
Tricuspid valve replacement after cardiac transplantation. (2005) (16)
The Effect of β-Blocker Use on Cyclosporine Level in Cardiac Transplant Recipients (2005) (15)
Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors. (2016) (15)
Carvedilol in the failing heart (2001) (14)
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. (2021) (14)
Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function. (2009) (14)
Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy. (2013) (13)
Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. (2012) (13)
Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy (2018) (13)
Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart. (1987) (13)
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. (2006) (12)
Carvedilol produces sustained long-term benefits: follow-up at 12 years. (2009) (12)
Computerized practice guidelines for heart failure management: the HeartMan system. (1995) (11)
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. (2003) (11)
Left ventricular perforation after Impella® placement in a patient with cardiogenic shock (2018) (10)
Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction. (2008) (10)
Predictors of clinical outcomes in patients given carvedilol for heart failure. (2006) (9)
Allograft rejection in patients supported with continuous-flow left ventricular assist devices. (2011) (9)
The quantitative flow cytometric plasma OKT3 assay. Its potential application in cardiac transplantation. (1989) (9)
Effects of carvedilol on cardiovascular hospitalizations in patients with chronic heart failure (1996) (9)
The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients. (2004) (9)
Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients. (2011) (8)
188 Changing Patterns in the Utilization of Cardiac Allografts – Is It Time To Abandon the High-risk Donor? An Analysis of the U.S. Scientific Registry of Transplant Recipients (2011) (8)
Heart failure in community practice: relationship to age and sex in a beta-blocker registry. (2006) (8)
Cost-effectiveness of beta-blocker treatment in heart failure. (2002) (8)
B-cell function in chronic heart failure: antibody response to pneumococcal vaccine. (2001) (8)
AUGMENTED DIGOXIN CONCENTRATIONS WITH CARVEDILOL DOSING IN MILD‐MODERATE HEART FAILURE (1994) (7)
Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. (2020) (6)
Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. (2010) (6)
Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance (2019) (6)
Use of enoximone in patients awaiting cardiac transplant. (1988) (6)
Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? (2015) (6)
Enoximone in severe heart failure: clinical results and effects on β-adrenergic receptors (1990) (5)
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians. (2000) (5)
Carvedilol: Therapeutic Application and Practice Guidelines (1998) (4)
The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure (2000) (4)
Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report. (1987) (4)
Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock (2016) (4)
A RANDOMIZED TRIAL OF THE IMMUNOSUPPRESSIVE EFFICACY OF VINCRISTINE IN CARDIAC TRANSPLANTATION (1990) (4)
Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure (2007) (4)
111: Safety and Outcomes with Newer Treatment Strategies for Cardiac Antibody-Mediated Rejection: Still in the Woods (2010) (3)
Therapy of idiopathic dilated cardiomyopathy with chronic β-adrenergic blockade (2005) (3)
IMPACT OF REMOTE, WIRELESS PULMONARY ARTERY HEMODYNAMIC MONITORING IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: INSIGHTS FROM THE CHAMPION TRIAL (2012) (3)
646 Mechanical Unloading with Continuous-Flow Left Ventricular Assist Devices: Effects on Left Atrial Remodeling (2011) (3)
Results of A Multicenter, Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects with Stable Chronic Heart Failure (The COMPARE Trial) (10/7/08) (2008) (3)
Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database (2022) (3)
Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program. (2004) (3)
Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure (2000) (3)
Structural and Functional Myocardial Improvement Following Continuous-Flow Mechanical Unloading in Chronic Ischemic and Non-Ischemic Cardiomyopathy (2015) (3)
Rationales and choices for the treatment of patients with NYHA class II heart failure (2017) (3)
821-2 Characteristics of heart failure patients in clinical practice: How do they relate to ejection fraction? (2004) (2)
How Do (cid:1) -Blockers Improve Ventricular Function in Patients With Congestive Heart Failure? (2003) (2)
Abstract 14639: Changes In Expression of Cholesteryl Ester Transfer Protein (CETP) Are Correlated with Improvement in Left Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction Who Respond to {beta}-blocker Therapy (2012) (2)
066 - Real-Time Assessment of Patient Reported Outcomes in Heart Failure Clinic (2017) (2)
121 The Intermountain Risk Score Predicts Post-Transplant Survival When Calculated from Pre-Transplant Clinical Laboratory Values (2011) (2)
Virtual Outpatient Heart Failure Care - Lessons From the Covid-19 Era (2020) (2)
Abstract 16844: Uncoupling of Myocardial Response to Hypoxia in Nonischemic Heart Failure is Associated with Intraventricular Conduction Disease and Reduced Response to Beta-Blockers (2011) (2)
Cardiovascular deaths in heart transplant recipients: Does the rejection pattern matter? (2005) (2)
RNA Sequencing, Microarray Hybridization, and Quantitative PCR Produce Complementary, Concordant Results in Longitudinal Analysis of Myocardial Gene Expression in Dilated Cardiomyopathy Patients (2014) (2)
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report. (2022) (2)
Tuberculosis in a solid-organ transplant recipient: modern-day implications. (2009) (2)
Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3). (1990) (2)
A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices (2014) (2)
Outward Remodeling of Coronary Arteries in Cardiac Allograft Vasculopathy Is Reduced Compared to Native Atherosclerosis (2013) (2)
Effect of mechanical circulatory support on outcomes after heart transplantation in the modern era (2004) (2)
FEASIBILITY AND EFFECTIVENESS OF A SHOCK TEAM APPROACH IN REFRACTORY CARDIOGENIC SHOCK: PRELIMINARY RESULTS (2018) (2)
Cardiac Rotational Mechanics as a Predictor of Favorable Functional and Structural Response After Mechanical Unloading With Cardiac Assist Devices in Advanced Heart Failure Patients (2015) (2)
1172-71 Practical predictors of clinical outcomes in patients initiating beta-blockers for heart failure: Findings of a community-based registry (2004) (1)
INHIBITION OF ANGIOTENSIN SIGNALING REDUCES INCIDENCE OF ANTIBODY MEDIATED ALLOGRAFT REJECTION. (2010) (1)
OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques. (1988) (1)
821-1 Should beta-blockers be used before angiotensin converting enzyme inhibitors in patients with chronic heart failure? Meta-analysis of the prognostic benefit conferred by beta-blockers in patients not receiving ACE inhibitors (2004) (1)
248 Antibody-Mediated Rejection in Patients Bridged to Heart Transplantation with Mechanical Circulatory Support (2011) (1)
FEASIBILITY AND EFFECTIVENESS OF A MULTIDISCIPLINARY TEAM APPROACH IN REFRACTORY CARDIOGENIC SHOCK: A PROSPECTIVE PILOT STUDY (2016) (1)
Left Ventricular Assist Device-Associated Allosensitization - Much More Than a Nuisance (2015) (1)
Enhanced monocyte tissue factor procoagulant activity in heart failure is associated with apoptosis (2002) (1)
Initiation and use of beta-blockers in class IV heart failure (2004) (1)
Effect of carvedilol on symptom score in heart failure (1998) (1)
Changes in Hemoglobin Associated with Different Unloading Conditions in Patient Supported with Continuous Flow Left Ventricular Assist Devices (2011) (1)
Myocardial Gene Expression Associated With Right- and Left-Ventricular Remodeling With Beta-Blockade in Idiopathic Dilated Cardiomyopathy (2012) (1)
409 Laboratory Monitoring of Cell-Mediated Immunity and Cytokines in Cardiac Transplant Recipients for Prediction of Infection Episodes (2011) (1)
Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade. (1991) (1)
Titration, tolerability, and results of beta-blocker therapy for heart failure in the community: Findings of a community-based registry (2003) (1)
Double-blind, placebo-controlled (P), comparison of enoximone (E) and dobutamine (D) infusions in moderate to severe congestive heart failure patients (NYHA III–IV) (1991) (1)
Exertional Angina Due To Fused Aortic Bioprosthesis During Left Ventricular Assist Device Support: Two Cases and Review of the Literature. (2017) (1)
Utilization and Impact of Right Heart Catheterization on In-hospital Mortality, Length of hospital Stay and 30 Day Readmission in Patients Admitted with Cardiogenic Shock - Review of Large, National, Multicenter Database (2018) (1)
Quilty Revisited: Association with pAMR and Worse Outcomes Post Heart Transplantation (2013) (1)
Correction: Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance (2019) (1)
Efficacy of Left Ventricular Assist Device Therapy in Cold and Dry Chronic Heart Failure Patients. (2020) (1)
Clinical and Prognostic Significance of C3d and C4d Positive Immunopathology Pattern Versus C4d Positive Alone (2013) (1)
198: Fibrin deposition in cardiac allograft rejection: An incidental finding or a prognostic marker? (2007) (1)
Abstract 19188: Effects of Continuous-Flow Left Ventricular Assist Device Unloading on the Diastolic Function of the Failing Human Heart (2012) (1)
Effect of inhaled β-agonists on outcome in heart failure (1999) (1)
Vascular Function And Oxidative Stress: In Health, Heart Failure, Heart Transplantation, And Beyond: 814 (2011) (1)
Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure. (2009) (1)
Improved ventilatory response at peak exercise despite no change in peak oxygen consumption with chronic beta-blockade in heart failure patients (2002) (1)
821-3 Evaluation of beta-blocker does in community-based treatment of heart failure (2004) (1)
Sex Differences in the Risk of Pump Thrombosis in Patients Supported with Left Ventricular Assist Devices (2018) (1)
Performing a myocardial biopsy in a cardiac transplant patient with a persistent left superior vena cava (2009) (1)
200 Does Prolonged Continuous-Flow LVAD Unloading Induce Hypertrophy Regression to the Point of Atrophy in the Failing Human Heart? (2012) (1)
Does Surgeon Training or Hospital (Pediatric vs. Adult) Affect Survival after Heart Transplant in Adults with Congenital Heart Disease (2013) (1)
C4d in antibody-mediated rejection-how sensitive is it? (2005) (0)
Anxiety is common in patients with heart failure and symptoms of depression (2004) (0)
508 Microvessel Density in Cardiac Allograft Biopsies in Patients with Clinically Significant Coronary Allograft Vasculopathy Treated with Sirolimus (2011) (0)
CAN ECHOCARDIOGRAPHIC EVALUATION OF CARDIOPULMONARY HEMODYNAMICS REPLACE RIGHT HEART CATHETERIZATION IN END-STAGE HEART FAILURE PATIENTS AWAITING TRANSPLANTATION? (2010) (0)
Predicting Cardiac Recovery before Durable Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients (2019) (0)
Abstract 18127: Gene Expression Changes Associated With {beta}-Blocker Reverse Remodeling in the Failing Human Heart Constitute a {beta}1-Adrenergic Receptor Gene Regulatory Network (2013) (0)
Echocardiographic Patterns of Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction (2019) (0)
B2‐mediated glucose production during carvedilol and metoprolol titration in heart failure (2005) (0)
Fibrin on Endomyocardial Biopsy: A Significant Predictor of Cardiovascular Mortality beyond pAMR Score (2013) (0)
DOES OBESITY AFFECT RESPONSE TO TREATMENT IN ACUTE DECOMPENSATED HEART FAILURE? A DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) TRIAL SUBSTUDY (2011) (0)
Myocardial Capillary Loss in Cardiac Allograft Vasculopathy: A Longitudinal Case-Control Study (2016) (0)
Assessment of Response to Carvedilol in Heart Failure Patients Utilizing Echocardiographic Measurements of Systolic and Diastolic Parameters (2008) (0)
Carvedilol Exhibits No Tolerance to α1-Receptor Blockade in Class C Heart Failure Subjects (2007) (0)
Beta blockers for congestive heart failure [1] (multiple letters) (1998) (0)
The β-Adrenergic Receptor-G Protein-Adenylate Cyclase Complex in Idiopathic Dilated Cardiomyopathy (1990) (0)
Time-Dependent Changes in Serum B-Type Natriuretic Peptide (BNP) after Heart Transplantation: Correlation with Rejection Patterns and Allograft Function (2006) (0)
Cardiac Metabolism Gene Expression Differences in Patients With Advanced Ischemic Versus Non-Ischemic Cardiomyopathy (2014) (0)
Effects of β-Blocker Titration on Glucose Homeostasis in Heart Failure (2009) (0)
Abstract 12719: Expression of DHRS7c, A Novel Cardiomyocyte-expressed Gene Affected by Adrenergic Stimulation, is Strongly Associated With Ventricular Reverse-remodeling in Dilated Cardiomyopathy (2015) (0)
Type and Extent of HLA Mismatch and Antibody-Mediated Rejection in Heart Transplantation (2013) (0)
Abstract 15921: Alpha-2C Adrenergic Receptor Genotype is Strongly Associated With Changes in the Beta1-gene Signaling Network in Nonischemic Dilated Cardiomyopathy Patients Undergoing Beta-blocker Therapy (2017) (0)
Beta-blockade in women with heart failure in the community setting: insights from a large prospective beta-blocker registry (2004) (0)
Cluster Analysis in Idiopathic Dilated Cardiomyopathy (IDC): Opportunity to Define Pathogenesis? (2015) (0)
A Comprehensive Analysis of Trends in Demographics, Interventions and Outcomes Among Patients with Hypertrophic Cardiomyopathy: A Nationwide Inpatient Sample Registry Study (2018) (0)
186: Differential Sensitization Incidence between HeartMate I and HeartMate II Left Ventricular Assist Devices (2009) (0)
428 Diffusion Tensor Magnetic Resonance Imaging: A New Tool To Evaluate Cardiac Remodeling Changes in the Failing Human Heart (2012) (0)
Carvedilol produces sustained benefits over 12 years of follow-up (2004) (0)
72 Reduced Pulsatility in Patients Supported with the Continuous-Flow Left Ventricular Assist Device HeartMate II Is Associated with Increased Bleeding Events (2012) (0)
97: What Are the Best Antibody Predictors of AMR Resulting in Cardiac Death? (2010) (0)
Is The Benefit Of CardioMEMS Lessened In Elderly Patients With Heart Failure? (2022) (0)
A Novel Predictive Risk Score for Gastrointestinal Bleed Following Implantation of Continuous Flow Left Ventricular Assist Device (2018) (0)
509 The Role of Post-Mortem Examination in a Cardiac Transplant Program: Lessons from 101 Autopsies over 25 Years at Utah Transplant Affiliated Hospitals (2011) (0)
40 A Longitudinal Study of the Course of Untreated Antibody-Mediated Rejection in Heart Transplantation (2011) (0)
Predictors of Favorable Outcome in Patients Bridged to Transplant with Temporary Mechanical Circulatory Support Devices (2019) (0)
Cardiogenic Shock and Short-Term Mechanical Circulatory Support Options in the Current Era: Focus on Adverse Events (2018) (0)
Can C1q in Endomyocardial Biopsies (EMB) Predict AMR and Adverse Outcome (2013) (0)
Mixed Cellular and Antibody-Mediated Rejection in Heart Transplantation: A Distinct Entity or Simply the Sum of Two? (2015) (0)
Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties (2016) (0)
Safety and Efficacy of a De-Escalating Dose Regimen of rATG for Induction Therapy in Heart Transplantation: A Single Center Experience.: Abstract# C1602 (2014) (0)
Blockade WithBucindolol inHeartFailure CausedbyIschemic VersusIdiopathic Dilated Cardiomyopathy (1991) (0)
32 Microvessel Density in Cardiac Allograft Biopsies of Patients with Clinically Significant Coronary Allograft Vasculopathy (2011) (0)
716: The Impact of 2006 United Network for Organ Sharing Thoracic Organ Allocation Policy Change: Mission Accomplished? (2009) (0)
Mechanical Circulatory Support Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic (2013) (0)
2: Virtual Crossmatch Should Be Utilized in Sensitized Patients To Improve Organ Allocation (2008) (0)
Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization (2014) (0)
244: Effect of Mechanical Unloading on Fibrosis and Hypertrophy during Cardiac Remodeling in Humans (2010) (0)
371 Is the Allocation Advantage for LVAD Supported Heart Transplant Candidates in the US Still Justified? An OPTN/UNOS Analysis (2012) (0)
P2628Predicting cardiac recovery before durable left ventricular assist device implantation in advanced heart failure patients (2019) (0)
High Impact by Susan Sample Cardiologist ' s Studies Pump Research on Chronic Heart Failure (0)
269: Influence of pretransplant amiodarone on posttransplant cyclosporine pharmacokinetics and heart rate (2006) (0)
Beta-blockers in patients with left ventricular ejection fraction >40%: results from a community-based registry (2003) (0)
150 Interleukin 5 Predicts Antibody-Mediated Rejection in Cardiac Transplant Recipients (2011) (0)
The contribution of blood product transfusions to HLA allosensitization in LVAD recipients (2003) (0)
Predictors of Persistently Elevated Pulmonary Vascular Resistance after the Insertion of Implantable Left Ventricular Assist Devices (2006) (0)
Alterations of the Sympathetic Nervous System in Heart Failure (1994) (0)
Abstract 14777: Transcription of Select Homeobox Genes Increases in Patients with Heart Failure-Reduced Ejection Fraction Who Have Improvements in Left Ventricular Ejection Fraction on β-blocker Therapy (2012) (0)
Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices (2016) (0)
Capillary Damage and Fibrin in Heart Transplantation: Significant Impact on Survival with or without Rejection (2016) (0)
The Role of md-Generation Beta-Blocking Agents in Chronic Heart Failure (2008) (0)
289 Is a High AlloMap® Score in the Absence of Cellular Rejection Associated with Antibody-Mediated Rejection? (2011) (0)
Functional and Structural Effects of Continuous-Flow Left Ventricular Assist Device Unloading on the Failing Human Heart: A Prospective, Single-Center Study (2012) (0)
Prior HLA allosensitization predisposes patients to become and remain highly sensitized after LVAD implantation (2003) (0)
Low-dose prophylactic intravenous immunoglobulin does not prevent HLA allosensitization in LVAD recipients (2004) (0)
262 Markov Chain Analysis of Time Dependent Changes in AMR Using the 2011 ISHLT pAMR Classification (2012) (0)
Amyloidosis Cardiomyopathy Demonstrates Distinct Echocardiographic Patterns Compared to Patients with Heart Failure with Preserved Ejection Fraction (2016) (0)
Abstract 19802: Implantable Hemodynamic Monitoring Reduces Heart Failure Hospitalizations Due to Congestion Regardless of Perfusion Status (2015) (0)
In-hospital initiation of beta-blocker therapy for heart failure (2002) (0)
Readmission Rates in Patients with Left Ventricular Assist Devices (2016) (0)
367: Clinical and Hemodynamic Effects of Early Renin Angiotensin Aldosterone System Blockade in Cardiac Transplant Recipients (2009) (0)
Carvedilol initiation by community physicians in COHORE: comparison with U.S. carvedilol trials and compassionate use protocols (2002) (0)
Outcome of Adults with Congenital Heart Disease Evaluated for Heart Transplant: A Multi-Center Study (2013) (0)
192: The impact of a repetitive cellular or antibody-mediated rejection pattern on cardiovascular death in heart transplant recipients (2006) (0)
PII‐1 (2006) (0)
Impact of a Novel Shared Healthcare Delivery Model in Remotely Located Patients with Left Ventricular Assist Devices (2018) (0)
Improving Prediction of Acute Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Devices Using Novel Comprehensive Eighteen-Segment Echocardiographic Strain Analysis (2021) (0)
Antibody-Mediated Rejection in Heart Transplantation: Does Induction and the Type Matter? (2012) (0)
Transcriptional Profiles of Ventricular Ectopy on β-Blocker Therapy (2011) (0)
Stability of Cardiac Function after Left Ventricular Assist Device Weaning in End-Stage Heart Failure (2019) (0)
565 Characterization of the Failing Human Heart Via Diffusion Tensor Imaging: An Ex-Vivo Study (2011) (0)
the BEST trial The effect of diabetes on outcomes of patients with advanced heart failure in (2011) (0)
359: Virtual crossmatch improves organ allocation in sensitized patients (2007) (0)
Erratum: Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance (PLoS ONE (2019) 14: 8 (e0221519) DOI: 10.1371/journal.pone.0221519) (2019) (0)
535 Clinical Predictors and Risks Factors for Left Ventricular Assist Device Thrombosis in HeartMate II Supported Patients (2012) (0)
344 New ISHLT Pathologic Diagnosis of Suspicious AMR (pAMR1) Confers Increased Risk of Cardiovascular Mortality (2012) (0)
Sensitization in Left Ventricular Assist Device Recipients Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA (2013) (0)
Beta blockers for congestive heart failure. (1998) (0)
Renal dysfunction is more likely in recipients bridged to heart transplantation with inotropes than with left ventricular assist devices: an analysis of pre-transplant characteristics in the modern era (2004) (0)
Abstract 17397: Discovery and Validation of Novel Genes Predicting Cardiac Remodeling on {beta}-blockade (2010) (0)
451: Longitudinal Evaluation of Microvessel Density in Survivors Versus Non-Survivors of Cardiac Antibody-Mediated Rejection (2010) (0)
519 Does Immune System Activation from Cellular Rejection Trigger Antibody-Mediated Rejection in Heart Transplantation? (2011) (0)
Recovery of Myocardial Capillary Bed (Microvascular) Density Persists in Long Term Follow Up of CAV Patients Treated With Sirolimus (2014) (0)
Transcriptional Profiles of Reverse Remodeling (2010) (0)
Are the Clinical Implications of Lactic Acidosis Similar Post-Cardiac Transplantation Verus Post-LVAD Implantation? (2013) (0)
The value of B-type natriuretic peptide in predicting allograft rejection in cardiac transplant recipients (2004) (0)
Discovery and Validation of Novel Genes in Cardiac Remodeling (2010) (0)
574 Impact of Sildenadfil Therapy on Heart Transplant Recipients with Non-Reversible Pulmonary Hypertension (2011) (0)
The impact of a positive donor-specific crossmatch on outcome after heart transplantion (2003) (0)
Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction (2018) (0)
193: Antibody-Mediated Rejection in Heart Transplantation: More Than Present-or-Absent (2008) (0)
183 Impact of Donor Left Ventricular Hypertrophy on Cardiac Transplant Recipients Outcomes (2011) (0)
PATIENT HEALTH STATUS TRAJECTORIES IN HEART FAILURE WITH RECOVERED EJECTION FRACTION (2019) (0)
Do Ischemic Cardiomyopathy and Cardiac Allograft Vasculopathy Have Unique Myocardial Remodeling Characteristics (2011) (0)
Impact of Donor and Recipient Socio-economic Status (SES) on Outcomes in Adult Heart Transplantation: Does It Really Matter? (2014) (0)
Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy (2013) (0)
human heart. Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing (2013) (0)
Outcomes of Restrictive Cardiomyopathy Following LVAD Placement: An IMACS Analysis (2020) (0)
(909) - Unique Characteristics of Allograft Microvasculature in Patients with Severe Symptomatic Cardiac Allograft Vasculopathy (2017) (0)
252: Nuclear stress myocardial perfusion imaging compares favorably to dobutamine stress echocardiography in detection of CAV (2007) (0)
385: Advanced Cardiac Allograft Vasculopathy Results in a Unique Cardiac Remodeling Pattern (2009) (0)
β-blocker related improvement in exercise capacity is associated with increased expression of SR Ca+2-ATPase (1999) (0)
44 The Revised Pathologic Diagnosis of AMR Identifies Patients at Risk of Cardiovascular Mortality (2012) (0)
511: Impact of High Dose Inotropic Donor Support on Early Myocardial Necrosis and Outcome in Cardiac Transplantation (2010) (0)
Inhibition intheFailing HumanHeart4 (2015) (0)
Failing Human Ventricular Myocardium (2005) (0)
IMPROVING HEART FAILURE CARE:Strategies for Increasing Utilization of Beta-Blockade. In-Hospital Initiation of Beta-Blocker Therapy for Heart Failure (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edward Michael Gilbert?

Edward Michael Gilbert is affiliated with the following schools:

University of Utah